BLOOMBERG: Merck KGaA Raises Sales Forecast on Rebif Profit

  

Marcus Kuhnert, chief financial officer at Merck KGaA, talks about raising the company’s full-year sales forecast on higher revenue from its top-selling medicine Rebif. He speaks with Jonathan Ferro on “On The Move.”